prostatic cancer
Conditions
Interventions
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients voluntarily joined the study and signed the informed consent. 2. Aged >=18 and =3 months.
Exclusion criteria
Exclusion criteria: 1. Had received epomycin within 1 year before administration of the study drug. 2. Severe allergic to epomycin. 3. Patients with grade 3 or above peripheral neurotoxicity during previous chemotherapy. 4. Currently receiving other anti-tumor therapy. 5. Clinically significant mental or central nervous system disorders. 6. Brain metastases with clinical symptoms. 7. Major surgery, or radiotherapy, within 28 days prior to study initiation, or elective surgery required during the study period. 8. Received Chinese herbal or proprietary medicine treatment within 7 days prior to the start of study treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PSA remission rate; | — |
Countries
China
Contacts
Public ContactShi Yanxia
Sun Yat-sen University Cancer Center
Outcome results
None listed